The above results confirmed our hypothesis based on the analysis of data obtained from the GEO database; that is, the expression of TFRC in AML cells treated with Ara-C was not significantly decreased, which enables the effective inhibition of the development of AML cells by Ara-C@HFn. The gene discussed is TFRC; the disease is acute myeloid leukemia.